Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ryosuke Miyatake"'
Autor:
Hideaki Hayashi, Toshihiko Ohkami, Yoshitaka Uchida, Goro Fukami, Takuya Asaka, Takayuki Shibuya, Tsuyoshi Sasaki, Tasuku Hashimoto, Hiroyuki Watanabe, Eiji Shimizu, Masaomi Iyo, Kenji Hashimoto, Yukihiko Shirayama, Nobuhisa Kanahara, Yoshimoto Sekine, Hiroshi Yamanaka, Makoto Asano, Ryosuke Miyatake, Mihisa Fujisaki
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33:410-415
Although to date there have been no conclusive pathophysiological findings in support of the degenerative theory of the etiology of schizophrenia, the results of neuroimaging studies have suggested that progressive changes in the brain do occur durin
Autor:
Tokutaro Komiyama, Nobuhisa Kanahara, Hiroshi Ujike, Ryosuke Miyatake, Kenji Hashimoto, Norio Ozaki, Mitsuhiko Yamada, Ichiro Sora, Mutsuo Harano, Nakao Iwata, Toshiya Inada, Yoshimoto Sekine, Masaomi Iyo
Publikováno v:
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. :233-238
Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of DA transporter, which is a target of methamphetamine (METH). A recent large-scale gene-association study
Autor:
Tokutaro Komiyama, Ryosuke Miyatake, Nakao Iwata, Yoshimoto Sekine, Hiroshi Ujike, Masaomi Iyo, Yoichi Mashimo, Toshiya Inada, Ichiro Sora, Eiji Shimizu, Akira Sawa, Yoichi Suzuki, Daisuke Matsuzawa, Mutsuo Harano, Kenji Hashimoto, Yukihiko Shirayama, Kazuhisa Maeda, Mitsuhiko Yamada, Norio Ozaki, Akira Hata
Publikováno v:
American Journal of Psychiatry. 164:1105-1114
Protein interacting with C-kinase-1 (PICK1) plays a role in the targeting and clustering of dopamine transporter, which is the primary target site for the abused drug methamphetamine. Based on the interaction of PICK1 with dopamine transporter, it is
Publikováno v:
Psychiatry and Clinical Neurosciences. 58:359-363
Several pharmacological studies suggest the possible involvement of sigma(1) receptors in the pathogenesis of schizophrenia. An association has been reported between schizophrenia and two variants (GC-241-240TT and Gln2Pro) in the sigma(1) receptor g
Publikováno v:
Biological Psychiatry. 55:85-90
Sigma1 receptors are involved in the pathogenesis of drug abuse. Two polymorphisms (GC-241-240TT and Gln2Pro) in the sigma1 receptor gene (SIGMAR1) have been identified. To investigate the role of SIGMAR1 in conveying susceptibility to alcoholism, we
Publikováno v:
Molecular Psychiatry. 7:1101-1106
N-methyl-D-aspartate (NMDA) receptor dysfunction is involved in the pathogenesis of schizophrenia. We determined the nucleotide sequence of the 5'-upstream region of the human NMDA receptor 2B (NR2B) subunit gene and identified a novel T-200G variant
Autor:
Ryosuke Miyatake, Kiyoshi Hosokawa, Hiroshi Suwaki, Hirohito Yoneyama, Taira Ohnishi, Yoshiyuki Ichikawa, Kazuhiko Iwahashi, Kazuhiko Nakamura
Publikováno v:
Neuropsychobiology. 33:76-79
The effect of a neuroleptic, haloperidol (HP), on nitric oxide formation catalyzed by neuronal nitric oxide synthase (n-NOS) in the porcine brain was investigated. HP inhibited n-NOS activity noncompetitively versus L-arginine as a substrate, decreas
Autor:
Norio Ozaki, Nakao Iwata, Daisuke Matsuzawa, Toshiya Inada, Kenji Hashimoto, Tokutaro Komiyama, Ryosuke Miyatake, Mitsuhiko Yamada, Tasuku Hashimoto, Ichiro Sora, Mutsuo Harano, Yoshimoto Sekine, Hiroshi Ujike, Masaomi Iyo
Publikováno v:
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. (7)
Accumulating evidence suggests that oxidative stress plays a role in the mechanisms of action of methamphetamine (METH) in the brain. In the present study, we investigated the association between the genetic polymorphisms among glutathione (GSH)-rela
Autor:
Eiji Shimizu, Masaomi Iyo, Hiroyuki Watanabe, Kenji Hashimoto, Takashi Kojima, Hiroko Hagiwara, Mihisa Fujisaki, Ryosuke Miyatake
Publikováno v:
Progress in neuro-psychopharmacologybiological psychiatry. 31(1)
Although preclinical studies suggest that methylone (2-methylamino-1-[3,4-methylenedioxyphenyl]propan-1-one) and 5-MeO-MIPT (5-methoxy-N-methyl,N-isopropyl tryptamine) may have psychostimulant properties, the scientific reports about the clinical eff
Autor:
Eisaku Okuyama, Ryosuke Miyatake, Kazuhiko Iwahashi, Yoshiyuki Ichikawa, Aizou Furukawa, Yoshinori Matsuo, Kazuhiko Nakamura
Publikováno v:
Clinica Chimica Acta. 252:197-199